Ranitidine tablets ip 300 mg?

Ranitidine tablets IP 300 mg are a form of the drug ranitidine, an H2 receptor blocker that reduces stomach acid production.

What they’re used for (general indications)
- Short-term treatment of GERD (acid reflux) and erosive esophagitis
- Peptic ulcers (gastric/duodenal)
- Dyspepsia and other acid-related symptoms
- Sometimes used for NSAID-induced ulcers or Zollinger-Ellison syndrome (under specialist care)

Typical dosing (adult, general guidance)
- Common regimens: 150 mg twice daily or 300 mg at bedtime
- For ulcers or more severe symptoms: up to 300 mg twice daily (600 mg/day) may be used under medical supervision
- Always follow your doctor’s or pharmacist’s instructions, as dosing depends on the condition being treated, its severity, and kidney function
- Take tablets with a full glass of water, with or without food
- Avoid taking antacids within 1 hour of a ranitidine dose if possible, as they can affect absorption of the drug

Important safety and regulatory notes
- In many countries, ranitidine has been restricted or withdrawn from the market due to concerns about a potential carcinogenic impurity (NDMA). Availability varies by country and over time.
- If you’re considering using ranitidine IP 300 mg, check with a local pharmacist or physician about current regulatory status and safer alternatives (for example, famotidine or certain proton pump inhibitors) that are available in your area.
- Before using if you’re pregnant or breastfeeding, or if you have kidney disease, talk to a healthcare professional.
- Report any severe or persistent side effects (like severe abdominal pain, yellowing of skin/eyes, dark urine, severe allergic reactions).

Common side effects (brief)
- Headache, dizziness
- Constipation or diarrhea
- Fatigue
- Rare: mental/mood changes, muscle weakness, liver test abnormalities

If you’d like, tell me your country or region and what you’re aiming to treat, and I can share current availability, typical guidelines, and safer alternatives specific to your area. What would you like to know next?